StonvexLoading…
StonvexStonvexStonvexCore line items from GCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $1.29B | $1.16B | $703.83M |
Operating Income | $144.98M | $130.62M | $110.08M |
Net Income | $137.37M | $125.81M | $94.11M |
EPS (Diluted) | $3.59 | $3.05 | $2.30 |
Total Assets | $1.20B | $1.07B | $846.91M |
Total Liabilities | $716.66M | $665.26M | $556.49M |
Cash & Equivalents | $379.78M | $259.76M | $183.28M |
Free Cash Flow OCF − CapEx | $182.79M | $142.54M | $129.07M |
Shares Outstanding | 38.23M | 41.20M | 9.33M |